AirNexis Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $200M

  • Investors
  • 6

AirNexis Therapeutics General Information

Description

Developer of novel therapeutic drugs designed to provide treatment to COPD patients. The company develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions that exert synergistic effects through a dual mechanism of action that promotes bronchodilation and reduces the release of inflammatory factors, enabling healthcare professionals to provide quality care to patients.

Contact Information

Website
www.airnexis.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • San Carlos, CA
  • United States
Primary Industry
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • San Carlos, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AirNexis Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 09-Jan-2026 $200M Completed Clinical Trials - Phase 1
To view AirNexis Therapeutics’s complete valuation and funding history, request access »

AirNexis Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Enavate Sciences Venture Capital Minority
Frazier Healthcare Partners PE/Buyout Minority
Goldman Sachs Asset Management Asset Manager Minority
Longitude Capital Venture Capital Minority
OrbiMed Growth/Expansion Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

AirNexis Therapeutics FAQs

  • When was AirNexis Therapeutics founded?

    AirNexis Therapeutics was founded in 2025.

  • Where is AirNexis Therapeutics headquartered?

    AirNexis Therapeutics is headquartered in San Carlos, CA.

  • What industry is AirNexis Therapeutics in?

    AirNexis Therapeutics’s primary industry is Biotechnology.

  • Is AirNexis Therapeutics a private or public company?

    AirNexis Therapeutics is a Private company.

  • What is AirNexis Therapeutics’s current revenue?

    The current revenue for AirNexis Therapeutics is .

  • How much funding has AirNexis Therapeutics raised over time?

    AirNexis Therapeutics has raised $200M.

  • Who are AirNexis Therapeutics’s investors?

    Enavate Sciences, Frazier Healthcare Partners, Goldman Sachs Asset Management, Longitude Capital, and OrbiMed are 5 of 6 investors who have invested in AirNexis Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process